Regarding prognosis, ALK-negative ALCL patients with a DUSP22 rearrangement have a similarly favorable outcome as ALK-positive ALCL patients, whereas TP63 rearranged ALK-negative ALCL patients usually display an aggressive clinical course [45,46,47]. Here, ALK is linked to anaplastic large cell lymphoma.